Top 10 Companies in the Pyrantel Pamoate Market (2026): Market Leaders Driving Global Parasite Treatment

Global Pyrantel Pamoate Market was valued at USD 129 million in 2025 and is projected to reach USD 164.12 million by 2034, expanding at a compound annual growth rate (CAGR) of 3.50% during the forecast period. The upward trend stems from rising parasite prevalence and a growing focus on healthcare in emerging economies.

Pyrantel pamoate is an anthelmintic medication widely used to treat parasitic worm infections, including roundworms, hookworms, and pinworms, in both humans and animals. It is particularly effective in the treatment of gastrointestinal worm infestations. Pyrantel pamoate works by paralyzing the worms, which allows the body to expel them through bowel movements. It is commonly available in tablet and liquid forms and is used globally to combat parasitic infections.

Pyrantel Pamoate Market – View in Detailed Research Report

---

🔟 1. Uquifa

Headquarters: Shanghai, China
Key Offering: Pyrantel pamoate tablets and liquid formulations

Uquifa has built a reputation for high‑purity anthelmintic ingredients and supplies both human and veterinary markets worldwide. The company’s manufacturing footprint spans multiple facilities in China, ensuring consistent quality and timely delivery.

Sustainability & Growth Initiatives:

• Investing in process‑efficiency upgrades to reduce carbon footprint.
• Expanding R&D into combination therapies for broader parasite coverage.
• Strategic partnerships with regional distributors to boost market penetration.

---

9️⃣ 2. Megafine

Headquarters: Mumbai, India
Key Offering: High‑quality pyrantel pamoate capsules and syrups

Megafine has positioned itself as a key supplier in the Indian market, leveraging local manufacturing to keep costs competitive while maintaining stringent quality controls. Its product portfolio extends to veterinary formulations, capturing a growing segment of pet owners.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling systems in production lines.
• Development of slow‑release delivery platforms to improve patient compliance.
• Collaborations with veterinary associations to promote deworming protocols.

---

8️⃣ 3. Ipca Laboratories

Headquarters: Bengaluru, India
Key Offering: Pyrantel pamoate tablets for human and animal use

Ipca Laboratories operates a dual‑channel strategy, supplying both domestic and export markets. Its emphasis on affordable pricing has broadened access in price‑sensitive regions.

Sustainability & Growth Initiatives:

• Adoption of green chemistry practices to minimize waste.
• Investment in digital supply‑chain solutions for traceability.
• Participation in public‑private initiatives to improve parasite awareness.

---

7️⃣ 4. Cosma

Headquarters: Milan, Italy
Key Offering: Formulated pyrantel pamoate products across dosage forms

Cosma’s global presence is reinforced by a network of distribution partners in Europe and beyond. The company focuses on delivering consistent quality across its product range.

Sustainability & Growth Initiatives:

• Enhanced packaging to reduce plastic usage.
• Research into novel excipients that improve solubility.
• Strategic alliances with veterinary clinics to expand market reach.

---

6️⃣ 5. Minsheng Medicine

Headquarters: Shanghai, China
Key Offering: Pyrantel pamoate in tablet and liquid formats

Minsheng Medicine has carved out a niche in the Chinese market through robust manufacturing capabilities and a strong distribution network that spans both urban and rural areas.

Sustainability & Growth Initiatives:

• Deployment of energy‑efficient production lines.
• Partnerships with local NGOs to improve health education.
• Expansion of product line to include combination therapies.

---

5️⃣ 6. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Veterinary deworming solutions, including pyrantel pamoate blends

Bayer’s long history in animal health positions it well to capitalize on the growing demand for deworming products. The company leverages its research capabilities to develop multi‑target formulations.

Sustainability & Growth Initiatives:

• Carbon‑neutral production targets by 2030.
• Investment in precision veterinary medicine.
• Collaboration with regional veterinary associations.

---

4️⃣ 7. Sanofi

Headquarters: Paris, France
Key Offering: Human antiparasitic drugs, including pyrantel pamoate

Sanofi’s global footprint and strong R&D pipeline allow it to address both human and animal markets. Its focus on patient adherence drives product development.

Sustainability & Growth Initiatives:

• Reduction of packaging waste across product lines.
• Support for global health initiatives targeting parasitic diseases.
• Digital health tools to improve treatment compliance.

---

3️⃣ 8. Pfizer Inc.

Headquarters: New York, USA
Key Offering: Pyrantel pamoate for human use, part of broader antiparasitic portfolio

Pfizer’s extensive distribution network ensures rapid market penetration. The company’s commitment to innovation fuels the development of next‑generation formulations.

Sustainability & Growth Initiatives:

• Use of renewable energy in manufacturing facilities.
• Research into biodegradable excipients.
• Partnerships with global health organizations.

---

2️⃣ 9. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Veterinary anthelmintics, including pyrantel pamoate

Merck’s focus on animal health has enabled it to capture a significant share of the deworming market. The company emphasizes evidence‑based product efficacy.

Sustainability & Growth Initiatives:

• Adoption of circular manufacturing principles.
• Investment in AI‑driven diagnostics for parasite detection.
• Engagement with veterinary training programs.

---

1️⃣ 10. GlaxoSmithKline

Headquarters: Brentford, UK
Key Offering: Human antiparasitic therapies, including pyrantel pamoate

GlaxoSmithKline’s global reach and strong regulatory expertise support its presence in both developed and emerging markets. The company’s portfolio is tailored to meet diverse therapeutic needs.

Sustainability & Growth Initiatives:

• Goal to achieve net‑zero emissions by 2050.
• Development of low‑cost formulations for low‑income regions.
• Collaborations with international health agencies.

---

Download FREE Sample Report: Pyrantel Pamoate Market – View in Detailed Research Report

Get Full Report: Pyrantel Pamoate Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Pyrantel Pamoate

The market is steering toward integrated healthcare solutions that combine human and veterinary deworming strategies. As awareness of parasite‑related morbidity rises, stakeholders are focusing on streamlined supply chains and patient‑centric delivery models.

📈 Key Trends Shaping the Market:

• Growth of combination therapies that target multiple parasite species.
• Adoption of digital health platforms to monitor treatment outcomes.
• Increasing emphasis on eco‑friendly manufacturing practices.
• Expansion of deworming programs in low‑income regions.

---

📌 Future Trends

Innovation in drug delivery, such as micro‑encapsulated slow‑release formulations, is expected to improve adherence and reduce dosing frequency. Parallel advances in diagnostics will enable earlier detection and more precise treatment regimens, potentially reshaping the competitive landscape.